r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

BC

Bernadette Connaughton

Insider · Director · HALO

Bernadette Connaughton files insider transactions with the SEC as a director of Halozyme Therapeutics (HALO). We hold 5 disclosed purchases and sales filed since 11 September 2018, 2 of them in the last 90 days.

  • Files forHALO
  • Disclosed buys and sells5 in all, 2 in the last 90 days
  • Last disclosure11 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 7 September 2018 — 10 August 2026Director · Halozyme Therapeutics (HALO)28 Form 4 lines · source: SEC Form 4
  • Filed 26 October 2021 — 17 June 2026Director · Editas Medicine (EDIT)6 Form 4 lines · source: SEC Form 4
  • Filed 12 November 2019 — 28 September 2023Director · Syneos Health (SYNH)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

41 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.